GABA-A a5 agonists (AgeneBio)

N/A

Report date: 2025/01/26 18:56:13
NME

Base Information

Drug NameGABA-A a5 agonists (AgeneBio)
Drug Alias NameGABA A receptor alpha-5 subunit agonists (AgeneBio)BPN-27473
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor alpha-5 agonists
TargetsGamma-aminobutyric acid A receptor alpha-5
Therapy Area/IndicationsSchizophreniaAutistic DisorderCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAgenebio Inc
China Registration ClassN/A

Develop Information

Active CompaniesAgenebio Inc
Inactive CompaniesN/A
Active IndicationsSchizophreniaAutistic DisorderCognition Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A